Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study
已完结10由 Aven 发布于 2025/11/12 9:49:55
DOI:10.1016/s1470-2045(25)00287-6
作者:Elena Elimova, Jaffer Ajani, Howard Burris, Crystal S Denlinger, Syma Iqbal, Yoon-Koo Kang, Jwa Hoon Kim, Keun-Wook Lee, Bruce Lin, Rutika Mehta, Do-Youn Oh, Sun Young Rha, Young Mi Seol, Lin Yang, Ma
文献类型:期刊论文
补充材料:只需要正文